Article info

PDF

Extended report
Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials

Authors

  1. Correspondence to Professor Joachim Sieper, Department of Medicine 1, Rheumatology, Charité Universitätsmedizin–Campus Benjamin Franklin, Hindenburgdamm 30, Berlin 12200, Germany; Joachim.sieper{at}charite.de
View Full Text

Citation

Sieper J, Porter-Brown B, Thompson L, et al
Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials

Publication history

  • Accepted May 12, 2013
  • First published June 13, 2013.
Online issue publication 
December 04, 2013

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.